These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 7999452

  • 1. Late effects of adjuvant therapy for breast cancer.
    Shapiro CL, Recht A.
    J Natl Cancer Inst Monogr; 1994; (16):101-12. PubMed ID: 7999452
    [No Abstract] [Full Text] [Related]

  • 2. Survivorship and complications of treatment in breast cancer.
    Mrozek E, Shapiro CL.
    Clin Adv Hematol Oncol; 2005 Mar; 3(3):211-22, 238. PubMed ID: 16166992
    [Abstract] [Full Text] [Related]

  • 3. [Leukemia in patients with breast carcinoma after adjuvant chemotherapy and/or postoperative radiotherapy].
    Sack H.
    Strahlenther Onkol; 1995 Jul; 171(7):420-1. PubMed ID: 7631268
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M, Kodama T.
    In Vivo; 2001 Jul; 15(4):319-25. PubMed ID: 11695224
    [Abstract] [Full Text] [Related]

  • 6. Side effects of adjuvant treatment of breast cancer.
    Shapiro CL, Recht A.
    N Engl J Med; 2001 Jun 28; 344(26):1997-2008. PubMed ID: 11430330
    [No Abstract] [Full Text] [Related]

  • 7. Still waiting after 110 years: the optimal use of ovarian ablation as adjuvant therapy for breast cancer.
    Wolff AC, Davidson NE.
    J Clin Oncol; 2006 Nov 01; 24(31):4949-51. PubMed ID: 17075110
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Adjuvant therapy for node-negative breast cancer: a cautious interpretation.
    Henderson IC.
    Important Adv Oncol; 1990 Nov 01; ():199-216. PubMed ID: 1691137
    [No Abstract] [Full Text] [Related]

  • 12. Early occurrence of acute myeloid leukemia following adjuvant radiotherapy and higher cumulative dose of cyclophosphamide in carcinoma breast.
    Srivastava A, Murari M, Datta NR.
    Indian J Cancer; 2004 Nov 01; 41(4):178-80. PubMed ID: 15659873
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E, Anselmo AP, Klersy C, Santoro M, Orlandi E, Pagnucco G, Lunghi F, Maurizi-Enrici R, Baroni CD, Lazzarino M, Mandelli F, Bernasconi C.
    Haematologica; 1998 Sep 01; 83(9):812-23. PubMed ID: 9825578
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Therapy-related hematologic neoplasias after breast cancer. Epidemiologic, etiologic and cytogenetic aspects and new risk factors according to published data and own results].
    Haase D, Hanf V, Schulz T.
    Med Klin (Munich); 2004 Sep 15; 99(9):506-17. PubMed ID: 15372180
    [Abstract] [Full Text] [Related]

  • 18. Breast cancer: metastatic.
    Johnston S, Stebbing J.
    Clin Evid; 2002 Jun 15; (7):1579-602. PubMed ID: 12230774
    [No Abstract] [Full Text] [Related]

  • 19. More evidence that locoregional radiation therapy improves survival: what should we do?
    Whelan T, Levine M.
    J Natl Cancer Inst; 2005 Jan 19; 97(2):82-4. PubMed ID: 15657332
    [No Abstract] [Full Text] [Related]

  • 20. [Current trends in the treatment of primary breast cancer].
    Letiagin VP.
    Vopr Onkol; 1998 Jan 19; 44(5):632-5. PubMed ID: 9884732
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.